Clinical Trial Update: Efficacy and Safety of RZL-012 on Submental Fat Reduction [Phase 2]

View source ↗

Summary

Phase 2 trial update on RZL-012 for submental fat reduction reports efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Submental Fat

Drugs mentioned

• RZL-012

Snippet

Sponsor: Raziel Therapeutics Ltd. | Conditions: Submental Fat | Phase 2 | Status: COMPLETED | Results posted: 2023-09-28